Poster Presentations

Title: Comparative Efficacy and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review (SLR) and Network Meta Analysis (NMA).

AUTHORS: Lebwohl M, Carvalho A, Asahina A, Zhang J, Fazeli MS, Kasireddy E, Serafini P, Ferro T, Gogineni R, Thaçi D.

Conference: EADV Congress 2024. October 14-17, 2024

Title: Systematic Review and Indirect Treatment Comparison of the Efficacy of Tildrakizumab vs Guselkumab or Risankizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis

AUTHORS: Abu-Hilal M, Serafini P, Balasubramanian G, Chan P, Ferro T.

Conference: Canadian Dermatology Conference. June 26-29, 2024.

Title: 1880-LB: Efficacy and Safety of iGlarLixi vs. IDegAsp in Non-Asian People with Type 2 Diabetes Inadequately Controlled with Basal Insulin—A Systemic Literature Review and Network Meta-analysis

AUTHORS: Philip Home; Felipe Lauand, Khier Djaballah; Francois Bourhis; Xuan Li; Khadija Hafidh; Roopa Mehta; Khadra Faraoun; Inan Anaforoglu; Mir-Masoud Pourrahmat

Conference: American Diabetes Association’s 84th Scientific Sessions. June 21–24, 2024

Title: A systematic literature review and meta-analysis of the real-world effectiveness, quality of life, and safety of tildrakizumab for moderate-to-severe plaque psoriasis.

AUTHORS: Scott Gottlieb, Aaron S. Farberg, Neal Bhatia, Mir Sohail Fazeli, Kimberly Hofer, Otto Lam, Vicki Barghout, Jacob Mathew, Thomas Ferro

Conference: SCALE. May 15-19, 2024

Title: Prevalence and incidence of dilated cardiomyopathy in the United States, France, Germany, Italy, Spain, and the United Kingdom: a systematic literature review

AUTHORS: Michael C. Myers, Amanda Berge, Yue Zhong, Sonomi Maruyama, Cindy Bueno, Arnaud Bastien, Kimberly Hofer, Ramandeep Kaur, Mir Sohail Fazeli, Negar Golchin

Conference: European Society of Cardiology Heart Failure. May 11-14, 2024

Title: Economic Burden and Healthcare Resource Utilization in Patients with Psoriatic Arthritis (PsA): A Systematic Literature Review

AUTHORS: Varga S, Walia S, Zema C, Pushkarna D, Dahan S, Fazeli MS, Choi J, Merola J

Conference: ISPOR 2024, May 5-8, 2024

Title: Economic Burden and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus (SLE): A Systematic Literature Review (SLR)

AUTHORS: Choi J, Pomponi S, Andonova A, Pushkarna D, Fazeli MS, Clarke AE

Conference: ISPOR 2024, May 5-8, 2024

Title: Predicting Overall Survival (OS) Benefit in Previously Untreated Metastatic Melanoma From Improvements in Response Outcomes: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)

AUTHORS: Leung L, Serafini P, Srinivasan S, Ejzykowicz F, Pourrahmat MM, Moshyk A, Kurt M

Conference: ISPOR 2024, May 5-8, 2024

Title: Prevalence of Genetic Dilated Cardiomyopathy: A Systematic Literature Review

AUTHORS: Michael C. Myers, Yue Zhong, Sonomi Maruyama, Cindy Bueno, Arnaud Bastien, Boris Breznen, Mir Sohail Fazeli, Negar Golchin

Conference: EPI|Lifestyle Scientific Sessions 2024, March 18–21, 2024

Title: Systematic literature review (SLR) of the sex-specific epidemiological burden of Psoriatic Arthritis (PsA) disease.

AUTHORS: Joseph F Merola, Stefan Varfa, Robert Carroll, Wei-Hua Huang, Carla Zema, Divya Pushkarna, Stephanie Dahan, Jiyoon Choi

Conference: AAD Annual Meeting, March 8-12, 2024

Title: Epidemiology, Economic Burden, and Humanistic Burden in Multiple Sclerosis Spasticity (MSS): A Systematic Literature Review (SLR)

AUTHORS: Drachenberg C, Nazar G, Pushkarna D, Viswanathan H, Fazeli MS

Conference: ISPOR EU 2023, November 12-15, 2023

Title: Recurrence-Free Survival (RFS) as a Surrogate Endpoint (SE) for Overall Survival (OS) in Resected Stage II/III Melanoma: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)

AUTHORS: Leung L, Kirkwood J, Srinivasan S, Dyer M, Qian A, Pourrahmat MM, Kasireddy E, May JR, Moshyk A, Kurt M

Conference: ISPOR EU 2023, November 12-15, 2023

Title: Patient-Centric-Approach and Personalized Clinical Trials to Increase Patients Participation in Drug Development: Insight from a Targeted Literature Review (TLR)

AUTHORS: Collet JP, Shouman W, Hofer K, Pourrahmat MM, Maposa P, Fazeli MS

Conference: ISPOR EU 2023, November 12-15, 2023

Title: Follow the Money: Reporting Public Contributions and Incentives on Research and Development Programs for Agenzia Italiana Del Farmaco (AIFA; ITALIAN MEDICINES AGENCY)

AUTHORS: Pourrahmat MM, Maposa P, del Aguila M, Fazeli MS

Conference: ISPOR EU 2023, November 12-15, 2023

Title: Prevalence and incidence of Sjögren’s disease: A systematic literature review.

AUTHORS: Jiyoon Choi, Kimberly Hofer, Nishu Gaind, Mir Sohail Fazeli, Robert Carroll, Antoine Sreih, Antonia Christodoulou

Conference: ACR Convergence, November 10-15, 2023

Title: Recurrence-Free Survival (RFS) As a Surrogate Endpoint for Overall Survival (OS) in Adults with Early-Stage Hepatocellular Carcinoma (HCC): A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)

AUTHORS: Leung L, Singh P, Ademisoye E, Hofer K, Qian A, Kim I

Conference: ISPOR US 2023, May 7-10 2023

Title: Evaluating Disease-Free Survival (DFS) As a Surrogate Endpoint (SE) for Overall Survival (OS) in Muscle-Invasive Urothelial Carcinoma (MIUC): An Analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare Data

AUTHORS: Leung L, Kanters S, Pourrahmat MM, Friedman H, Navaratnam P, Reardon G, Patel M, Teitsson S, Kurt M, Lotan Y

Conference: ISPOR US 2023, May 7-10 2023

Title: HBA1C Reduction with Digital Health Devices in Type 2 Diabetes (T2DM): A Meta-Analysis of Randomized Controlled Trials

AUTHORS: Lee F, Han-Burgess E, Kennedy A, Serafini P, Pourrahmat MM, Breznen B.

Conference: ISPOR US 2023, May 7-10 2023

Title: I6 – The clinical burden in patients with multivessel disease post-acute myocardial infarction: A systematic literature review

AUTHORS: Bahit M, Korjian S, Daaboul Y, Chi G, Kalayci A, Gabriel S, Cupples G, Fazeli M, Shaunik A, Gibson C.

Conference: AMCP 2023, 21-24 March 2023

Title: I5 – Systematic literature review assessing the economic and humanistic burden of multivessel disease in patients with acute myocardial infarction.

AUTHORS: Baim, Gabriel S, Cupples G, Fazeli MS, Shaunik A.

Conference: AMCP 2023, 21-24 March 2023

Title: I3 – Assessing the multifactorial aspects of patient adherence to secondary preventative pharmacological therapies after an acute coronary syndrome

AUTHORS: Korjian S, Shaunik A, Nara P, Pourrahmat M, Breznen B, Gibson C.

Conference: AMCP 2023, 21-24 March 2023

Title: The economic and humanistic burden of multivessel disease in acute myocardial infarction: a systematic review.

AUTHORS: Korjian S, Bahit MC, Daaboul Y, Chi G, Karabay AK, Gabriel S, Cupples G, Fazeli MS, Shaunik A, Gibson C.

Conference: American College of Cardiology (ACC) 2023, 4-6 March 2023

Title: #959 Digital Interventions for Self-Management in Type 2 Diabetes Mellitus

AUTHORS: Lee FC, Han‐Burgess E, Kennedy A, Breznen B, Pourrahmat MM

Conference: ATTD 2023, 22-25 February 2023

Title: Disease-free survival (DFS) as a surrogate endpoint (SE) for overall survival (OS) in early-stage resected esophageal/gastroesophageal junction cancer (EC/GEJC): An analysis of SEER-Medicare data.

AUTHORS: Ajani JA, Leung L, Kanters S, Singh P, Kurt M, Kim I, Pourrahmat MM, Friedman HS, Navaratnam P , Reardon G

Conference: ASCO GI 2023, 19-21 January 2023

Title: Radiographic Progression-Free Survival (RPFS) as a Surrogate Endpoint for Overall Survival (OS) in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (MCRPC): A Correlation Meta-Analysis.

AUTHORS: Leung L, Patel M, Teitsson S, Hofer K, Qian A, Kurt M

Conference: ISPOR Europe 2022, 6-9 November 2022

Title: Exploring Endpoint Correlation Between Progression Free Survival (PFS) and Overall Survival (OS) in Previously Untreated Metastatic Melanoma Using Pseudo Individual Patient Data (IPD).

AUTHORS: Kanters S, Kurt M, Moshyk A, Leung L

Conference: ISPOR Europe 2022, 6-9 November 2022

Title: A Systematic Literature Review (SLR) of Comparative Efficacy Measures in Randomized Controlled Trials (RCTS) of Adjuvant Treatment in Localized Renal Cell Carcinoma (RCC).

AUTHORS: Ejzykowicz F, Kurt M, Dyer M, May JR, Shouman W, Kasireddy E, Pourrahmat MM

Conference: ISPOR Europe 2022, 6-9 November 2022

Title: Humanistic Burden of Informal Caregivers of Children and Young Adults With Newly Diagnosed Type 1 Diabetes (T1D): A Systematic Literature Review (SLR).

AUTHORS: Allen V, Bascle S, Cherkas A, Kasireddy E, Min R, Pushkarna D, Pourrahmat MM, Mahieu A

Conference: ISPOR Europe 2022, 6-9 November 2022

Title: Clopidogrel monotherapy following dual antiplatelet therapy in patients with acute coronary syndrome post-drug-eluting stent implantation: a systematic review and direct/indirect treatment comparison.

AUTHORS: D Sibbing, J Shan, F Bourhis, K Hofer, E Kasireddy, A Qian, I Khan

Conference: ESC 2022, 26-29 August 2022

Title: Dronedarone versus sotalol in patients with atrial fibrillation: a systematic literature review and network meta-analysis.

AUTHORS: B Kreidieh, J P Singh, C Blomstrom-Lundqvist, M P Turakhia, A J Camm, M S Fazeli, C Crotty, P R Kowey

Conference: ESC 2022, 26-29 August 2022

Title: EP057 / #753 – Efficacy And Safety Of Gla-300 Versusideg/Asp In People With Type 2 Diabetes(PWT2D): A Systematic Literature Review and Indirect Treatment Comparison (ITC)

AUTHORS: L. Zeng, Y. Huang, E. Shojaei, S. Behyan, P. Guyot, W. Landgraf.

Conference: Advanced Technologies & Treatments for Diabetes Conference (ATTD), 2022, April 27th-30th.

Title: Evaluating The Factors Associated With Patient Adherence And Persistence To Pharmacological Therapies After An Acute Coronary Syndrome

AUTHORS: Korjian S, Shaunik A, Nara P, Pourrahmat MM, Breznen B, Gibson CM

Conference: Quality of Care and Outcomes Research Scientific Sessions (QCOR), 2022, May 13th-14th.

Title: Determinants of adherence/persistence to positive airway pressure therapy in patients with obstructive sleep apnoea.

AUTHORS: R. Saad, V.K. Somers, G.S.Parks, D. Pushkarna, Fazeli MS, J. Black.

Conference: World Sleep Congress, 2022, March 11th-16th

Title: Indirect treatment comparison of efficacy and safety of insulin glargine 300U/mL with once-daily-insulin premix in T2DM.

AUTHORS: R. Ritzel, S. Ghosh, R. Emral, R. Malek, R. Malik, L. Zeng, Y. Huang, M.A. Mabunay, W. Landgraf, P. Guyot, E. Schenk, D. Pushkarna.

Conference: IDF 2021, December 6th-11th, 2021.

Title: Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in Previously Untreated Advanced Melanoma: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)

AUTHORS: Leung L, Chou E, Kurt M, Moshyk A, Hamilton M, Pourrahmat MM, Kanters S.

Conference: ISPOR EU 2021, November 30^th-December 3^rd, 2021.

Title: Surrogate Endpoints for Overall Survival (OS) in Advanced Melanoma: A Targeted Literature Review (TLR) of Correlation Meta-Analyses

AUTHORS: Pourrahmat MM, Leung L, Kurt M, Chou E, Kanters S, Moshyk A, Hamilton M.

Conference: ISPOR EU 2021, November 30^th-December 3^rd, 2021.

Title: Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) undergoing systemic therapy: a systematic literature review (SLR) and meta-analysis (MA) of real-world evidence (RWE).

AUTHORS: Long G, Tawbi H, Meyer N, Breznen B, Vyas C, Leung L, Moshyk A, Pushkarna D, Thakkar P, Fazeli MS, Kotapati S, Schadendorf D.

Conference: ESMO 2021, September 16^th-21^st, 2021.

Title: Efficacy and Safety of iGlarLixi vs IDegAsp: Systematic Review and Indirect Treatment Comparison (ITC).

AUTHORS: Home P, Mehta R, Hafidh K, Gurova O, Alvarez A, Serafini P, Pourrahmat MM.

Conference: Virtual ADA 2021, June 25^th-29^th, 2021.

Title: Use of Chimeric Antigen Receptor T cell Therapies in Patients With Large B-cell Lymphoma in the Real-World Setting: Systematic Literature Review.

AUTHORS: Liu F, Hofer K, Ardekani G, Parker C

Conference: EHA 2021, June 9^th-17^th, 2021.

Title: Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) treated with systemic therapy: A systematic literature review (SLR) and meta-analysis.

AUTHORS: Tawbi H, Long G, Meyer N, Breznen B, Vyas C, Leung L, Moshyk A, Pushkarna D, Thakkar P, Fazeli MS, Kotapati S, Schadendorf D

Conference: ASCO 2021, June 4^th-8^th, 2021.

Title: Analysis of Individual-Level Association of Progression-Free Survival (PFS) and Time to Treatment Failure (TTF) with Overall Survival (OS) for Previously Untreated Advanced Renal Cell Carcinoma Patients in the CheckMate 214 Trial

AUTHORS: Siliman G, Kanters S, Fazeli MS, Pourrahmat MM, Ejzykowicz F, Kurt M

Conference: Virtual ISPOR 2021, May 17^th-20^th, 2021.

Title: Understanding Hispanic/Latino participation in clinical trials and observational studies in the United States, and strategies to increase participation: A targeted literature review

AUTHORS: Ferri L, Kuri L, Ferri M, Dreyfus B, Doykos P, Andonova A, Hofer K, Fazeli MS

Conference: National Hispanic Medical Association, 24th Annual Conference. March 17^th-20^th, 2021.

Title: Indirect Costs of Oral Versus Non-Oral Therapies in Hematologic Malignancies: A Systematic Literature Review

AUTHORS: Fazeli MS., Pushkarna D., Howarth A., Hux M., Pourrahmat M-M., Chen C.

Conference: American Society of Hematology, Virtual. December 5^th-8^th, 2020.

Title: Effectiveness and Safety of Enoxaparin in Patients with Active Cancer and Venous Thromboembolism (VTE): A Systematic Literature Review

AUTHORS: Shan J, Sayre T, Hofer K, Shojaei E

Conference: ISTH 2020, July 12^th-14^th, 2020.

Title: Indirect Treatment Comparison (ITC) of IGlarLixi vs. IDegLira in Adults Inadequately Controlled by GLP-1 Receptor Agonists (GLP-1RAs)

AUTHORS: Home PD., Aroda VR., Fazeli MS., Whittington C., Goswami H., Shaunik A., Pourrahmat MM., Blonde L., Kalra S

Conference: ADA 2020, June 12^th-16^th2020.

Title: Health State Utility Values Across Cancer Types and Stages- A Systematic Literature Review

AUTHORS: Pourrahmat MM., Kansal AR., Chung KC., Hux M., Howarth A., Fazeli MS.

Conference: ISPOR 2020, Orlando, FL, USA. May 18th-20^th, 2020.

Title: Treatment Patterns in High-Risk, Bacille Calmette-Guérin Unresponsive Non-Muscle Invasive Bladder Cancer Patients- A Systematic Literature Review.

AUTHORS: Broughton E., Chun D., Gooden K., Hofer K., Fazeli MS.

Conference: ISPOR 2020, Orlando, FL, USA. May 18th-20^th, 2020.

Title: Placebo Effect in Knee Osteoarthritis- A Targeted Literature Review on The Challenges, Hypotheses, And Potential Solutions.

AUTHORS: Hofer K., Lin M., Pourrahmat MM., Fazeli MS.

Conference: ISPOR 2020, Orlando, FL, USA. May 18th-20^th, 2020.

Title: Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors and the Role of Auto-antibodies.

AUTHORS: Ferri L., Crocket G., Kuang Y., Breznen B., Fazeli MS.

Conference: American College of Rheumatology/ Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, Atlanta, GA, USA. November 8^th – 13^th, 2019.

Title: Prognostic Factors and Clinical Outcome Modifiers in Patients with Rheumatoid Arthritis: A Review.

AUTHORS: Ferri L., Crocket G., Han X., Breznen B., Fazeli MS.

Conference: American College of Rheumatology/ Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, Atlanta, GA, USA. November 8^th – 13^th, 2019.

Title: Epidemiology, Risk/Prognostic Factors, and Treatment Landscape in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Literature Review.

AUTHORS: Han X., Ferri L., Crocket G., Fazeli MS.

American College of Rheumatology/ Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, Atlanta, GA, USA. November 8^th – 13^th, 2019.

Title: The Effect of DMARDs on Cardiovascular Outcomes in Rheumatoid Arthritis: A Systematic Literature Review.

AUTHORS: Patel V., Ferri L., Han X., Mintzer L., Fazeli MS.

American College of Rheumatology/ Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, Atlanta, GA, USA. November 8^th – 13^th, 2019.

Title: Abatacept in Early Rheumatoid Arthritis: A Systematic Literature Review and Network Meta-Analysis.

AUTHORS: Paul D., Ferri L., Crocket G., Mintzer L., Fazeli MS.

European League Against Rheumatism (EULAR) Annual Meeting, Madrid, Spain. June 12^th–15^th, 2019.

Title: Comparative Safety Of Abatacept And Other Non-tumor Necrosis Factor Inhibitors In Rheumatoid Arthritis: A Systematic Literature Review And Network Meta-analysis

AUTHORS: Paul D, Taylor B, Kuang Y, Fazeli MS

European League Against Rheumatism (EULAR) Annual Meeting, Madrid, Spain. June 12^th–15^th, 2019.

Title: The comparative effectiveness of treatments after chemoradiation therapy (CRT) for unresectable stage III non-small cell lung cancer (NSCLC): A network meta-analysis.

AUTHORS: Dron L., Harari O., Fazeli MS., Zhang Y.

ISPOR 2019, New Orleans, LA, USA. May 18^th–22^nd, 2019.

Title: Humanistic and Economic Burdens of Triple-Negative Breast Cancer: A Literature Review.

AUTHORS: Fu AZ., Breznen B., Fazeli MS., Hux M., Kumar N., Davis C.

ISPOR 2019, New Orleans, LA, USA. May 18^th–22^nd, 2019.

Title: Treatment landscape in triple negative breast cancer: A systematic literature review.

AUTHORS: Fu AZ., Kuang Y., Fazeli MS., Kumar N., Davis C.

ESMO Breast Cancer 2019, Berlin, Germany. May 2^nd–4^th, 2019.

Title: Comparative efficacy of consolidation therapy after chemoradiation therapy (CRT) in patients with unresectable, locally advanced non-small cell lung cancer (LA-NSCLC): a network meta-analysis.

AUTHORS: Husain F., Harari O., Fazeli M., Zhang Y.

ISPOR 23rd Annual International Meeting, Baltimore, Maryland, USA. May 19^th–23^rd, 2018.

Title: Prevalence and timing of de-escalation therapy from ticagrelor to clopidogrel in acute coronary syndrome patients: results of a meta-analysis.

AUTHORS: Angiolillo D., Paek D., Shah R., Fazeli MS., Girotra S.

American College of Cardiology 67th Annual Scientific Session & Expo 2018 (ACC 2018), Orlando, Florida, USA. March 10^th–March 12^th.

Title: Transparency matters: use of digital software platform in replicating systematic reviews.

AUTHORS: Husain F., Sayre T., Feinman T., Fazeli M., Kuang Y., del Aguila MA.

ISPOR 20^thAnnual European Congress.Doctor Evidence LLC., Glasgow, Scotland. Nov. 4^th–8^th, 2017.

Poster Presentations

Address

Our Services

About